| |
 |
|
|
Inventor: Kimura; Tomio
Address: Ube, JP
No. of patents: 13
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 6063782 |
Pyrrolopyridazine derivatives |
May 16, 2000 |
| Pyrrolopyridazine derivatives having the general formula. ##STR1## In the above formula, R.sup.1 represents a C.sub.2 -C.sub.6 alkenyl-group, a halogeno-C.sub.2 -C.sub.6 -alkenyl group, a C.sub.6 -C.sub.10 aryl-C.sub.2 -C.sub.6 -alkenyl group, a C.sub.2 -C.sub.6 alkynyl group, a |
| 5688791 |
Aryl group-or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-hiv ag |
November 18, 1997 |
| Disclosed are an aryl group- or heterocyclic group-substituted aminoquinolone compound represented by the formula (Ia), (Ib) or (Ic): ##STR1## wherein each of the substitutents are defined in the specification, or a salt of the compound, and an AIDS curing agent containing the same a |
| 5519016 |
Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV a |
May 21, 1996 |
| Disclosed are an aryl group- or heterocyclic group-substituted aminoquinolone compound represented by the formula (Ia), (Ib) or (Ic): ##STR1## wherein each of the substitutents are defined in the specification, or a salt of the compound, and an AIDS curing agent containing the same a |
| 5496951 |
4-oxoquinoline-3-carboxylic acid derivatives their preparation and their use |
March 5, 1996 |
| Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy: R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial |
| 5436367 |
Intermediates for certain 4-oxoquinoline-3-carboxylic acid derivatives |
July 25, 1995 |
| Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial |
| 5436242 |
Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood plat |
July 25, 1995 |
| Compounds of formula (I): ##STR1## wherein R.sup.1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R.su |
| 5348961 |
4-oxoquinoline-3-carboxylic acid derivatives and their use |
September 20, 1994 |
| Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial |
| 5288726 |
Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and |
February 22, 1994 |
| Compounds of formula (I): ##STR1## wherein: R.sup.1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R.s |
| 5073556 |
4-oxoquinoline-3-carboxylic acid derivatives and their use |
December 17, 1991 |
| Compounds of formula (I): ##STR1## (in which: R.sup.1 represents fluorinated methoxy; R.sup.2 represents a nitrogen-containing heterocyclic group and R.sup.3 represents hydrogen or amino) and pharmaceutically acceptable salts, esters and amides thereof are valuable antibacterial |
| 4997943 |
Quinoline-3-carboxylic acid derivatives |
March 5, 1991 |
| Compounds of formula (I): ##STR1## (in which R.sup.1 is alkoxy, R is alkyl, haloalkyl, alkylamino, cycloalkyl or optionally substituted phenyl, X is chlorine or fluorine and Y is selected from certain specific heterocycles) have excellent antibacterial activity. They may be prepa |
| 4749704 |
Cyclopenta[d]pyrimidine derivatives and use as antidepressants |
June 7, 1988 |
| Compounds of formula (I): ##STR1## (wherein R.sup.1 and R.sup.2 are hydroxy, alkoxy, aryloxy or acyloxy or R.sup.2 is hydrogen, R.sup.3 is hydrogen or alkyl and R.sup.4 and R.sup.5 are hydrogen or various organic substituents) have valuable antidepressant activity and may be used |
| 4497957 |
Process for preparing optically active tryptophans |
February 5, 1985 |
| Biochemical optical resolution of DL-tryptophans in which DL-tryptophan amides are interacted with the culture products, or their treated products, of a microorganism capable of producing amidase is described. L-Tryptophan amides in racemic DL-tryptophan amides are asymmetrically hyd |
| 4443548 |
Process for preparing L-.alpha.-methylphenyl alanines |
April 17, 1984 |
| Biochemical optical resolution of DL-.alpha.-methylphenyl alanines in which DL-.alpha.-methylphenyl alanine amides are interacted with the culture products, or their treated products, of a microorganism capable of producing amidase is described. L-.alpha.-methylphenyl alanines having the |
|
|
|
